- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
COVID-19 and CT Scans: The Global Backlog, Rebound, and Implications
Elad Walach, Aidoc chief executive officer, discusses recent research into global CT imaging volume fluctuations and how providers should view that data.
CT imaging volumes are on the rebound globally, with Europe staying a week or two ahead of the United States. According to recently gathered and analyzed data, practices in the United States have already bounced back to 95 percent-to-97 percent of their pre-COVID-19 levels, and parts of Europe have already outpaced their pre-pandemic volumes. Some of the most significant changes in volume have been seen with stroke and pulmonary embolism images.
Diagnostic Imaging spoke with Elad Walach, chief executive officer of artificial intelligence solutions company Aidoc, about the company’s recent analysis of the worldwide fluctuations of CT scan volume during the COVID-19 outbreak. Walach put the findings into context and shared how providers should view it as the pandemic continues.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
